Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Sandra Ortega
Clinical Research Coordinator II
Cancer Center Division
Map Page
Research Area
lymphoma,
cancer treatment,
immunotherapy,
clinical trial,
drug combination
Grants
(1)
A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
2023
·
$0 / $188.6K
·
External
lymphoma,
cancer treatment,
immunotherapy,
clinical trial,
drug combination
Collaborations
(6)
Brianna Denton
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Carolyn Lane
Mutual work: 2 Proposals﹒1 Grant
Collaboration Details
Lora Inclan
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Niyuri Fleming
Mutual work: 1 Proposal
Collaboration Details
Sylvia DeCero
Mutual work: 1 Proposal
Collaboration Details
Page 1 of 2
Previous page
Next page
5+ Collaborators
$0 / $188.6K Funding
